PL371297A1 - Method of treating depression with delta receptor agonist compounds - Google Patents

Method of treating depression with delta receptor agonist compounds

Info

Publication number
PL371297A1
PL371297A1 PL02371297A PL37129702A PL371297A1 PL 371297 A1 PL371297 A1 PL 371297A1 PL 02371297 A PL02371297 A PL 02371297A PL 37129702 A PL37129702 A PL 37129702A PL 371297 A1 PL371297 A1 PL 371297A1
Authority
PL
Poland
Prior art keywords
receptor agonist
treating depression
agonist compounds
delta receptor
delta
Prior art date
Application number
PL02371297A
Other languages
English (en)
Polish (pl)
Inventor
Kwen-Jen Chang
William Pendergast
J.Peter Gengo
Original Assignee
Ardent Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardent Pharmaceuticals, Inc. filed Critical Ardent Pharmaceuticals, Inc.
Publication of PL371297A1 publication Critical patent/PL371297A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL02371297A 2001-10-29 2002-10-29 Method of treating depression with delta receptor agonist compounds PL371297A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34008401P 2001-10-29 2001-10-29
US33788701P 2001-11-02 2001-11-02

Publications (1)

Publication Number Publication Date
PL371297A1 true PL371297A1 (en) 2005-06-13

Family

ID=26990913

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02371297A PL371297A1 (en) 2001-10-29 2002-10-29 Method of treating depression with delta receptor agonist compounds

Country Status (11)

Country Link
US (1) US7030124B2 (enExample)
EP (1) EP1450807B1 (enExample)
JP (1) JP4892654B2 (enExample)
CN (1) CN1596113B (enExample)
CA (1) CA2464471C (enExample)
MX (1) MXPA04004059A (enExample)
NO (1) NO20042257L (enExample)
PL (1) PL371297A1 (enExample)
RU (1) RU2314809C2 (enExample)
TW (1) TW200300089A (enExample)
WO (1) WO2003037342A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60230869D1 (de) * 2001-05-18 2009-03-05 Astrazeneca Ab 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
US8476280B2 (en) * 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203300D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US7314880B2 (en) * 2003-01-02 2008-01-01 Mount Cook Biosciences, Inc. Cardioprotective delta opioid receptor agonists and methods of using same
BRPI0415165A (pt) 2003-10-01 2007-01-09 Adolor Corp composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem
HRP20120343T1 (hr) * 2004-08-02 2012-05-31 Astrazeneca Ab Derivati diarilmetil piperazina, njihovi pripravci i njihova uporaba
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
EP1874315A2 (en) * 2005-04-14 2008-01-09 Mount Cook Biosciences, Inc. Compositions of novel opioid compounds and method of use thereof
WO2007027987A2 (en) 2005-09-02 2007-03-08 Mount Cook Biosciences, Inc. Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
JP2011520956A (ja) * 2008-05-20 2011-07-21 アストラゼネカ・アクチエボラーグ 不安大うつ病性障害を処置する方法
CN103467460A (zh) * 2013-09-23 2013-12-25 昆明理工大学 一类含噻吩环和苄基的二芳基甲基哌嗪化合物及其应用
CN105646151B (zh) * 2016-02-26 2018-06-29 山西大学 一种炔类化合物及其制备方法和该化合物的用途
US10973815B2 (en) 2016-03-31 2021-04-13 Versi Group, Llc Delta opioid agonist mu opioid antagonist compositions and methods for treating Parkinsons disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
US20020052007A1 (en) 1992-02-03 2002-05-02 Chang Kwen Jen Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5681830A (en) * 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
HU221726B1 (hu) * 1993-07-30 2002-12-28 Ardent Pharmaceuticals Inc. Piperazinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
US6046200A (en) * 1994-09-09 2000-04-04 The United States Of America As Represented By The Secretary Of The Army Compositions having neuroprotective and analgesic activity
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
GB9709972D0 (en) * 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds
EP0952154B1 (en) * 1998-04-16 2004-08-18 Pfizer Products Inc. N-acyl and N-aroyl aralkyl amides
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904673D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904675D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
GB0017256D0 (en) * 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
DE60230869D1 (de) 2001-05-18 2009-03-05 Astrazeneca Ab 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen

Also Published As

Publication number Publication date
CA2464471A1 (en) 2003-05-08
US20030144299A1 (en) 2003-07-31
NO20042257L (no) 2004-06-24
JP4892654B2 (ja) 2012-03-07
CN1596113B (zh) 2010-05-26
EP1450807A1 (en) 2004-09-01
EP1450807A4 (en) 2008-06-25
WO2003037342A1 (en) 2003-05-08
CA2464471C (en) 2012-05-15
RU2004115748A (ru) 2005-03-27
JP2005508363A (ja) 2005-03-31
EP1450807B1 (en) 2013-12-25
CN1596113A (zh) 2005-03-16
US7030124B2 (en) 2006-04-18
RU2314809C2 (ru) 2008-01-20
MXPA04004059A (es) 2005-03-31
TW200300089A (en) 2003-05-16

Similar Documents

Publication Publication Date Title
EP1450807A4 (en) PROCESS FOR TREATING DEPRESSION WITH DELTA RECEPTOR AGONIST COMPOUNDS
EP1405219A4 (en) METHOD AND DEVICES FOR BUSINESS APPLICATION INTEGRATION
PL357927A1 (en) Method of obtaining trimethylpropane
IL147695A0 (en) Method of treating certain cancers using an estrogen agonist/antagonist
GB0128287D0 (en) Novel method and compounds
AU2002302243A1 (en) Method for determination of co-occurences of attributes
IL146598A0 (en) Method for the preparation of aggregates
PL353299A1 (en) Method of obtaining unsaturated silico-organic compounds
IL161073A0 (en) Composition and method for treating diabetes
GB2366639B (en) Method of comparing parts
AU2003214800A1 (en) Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
AU2002361357A8 (en) Method for monosulphonylation of an aminobenzofuran compound
GB0129008D0 (en) Method for forming matrices of hardened material
PL352866A1 (en) Novel isoindoloindolone compounds, method of obtaining tehm and pharmacological compoistion containing such compounds
GB0113408D0 (en) Autocatalytic coating method
AU2002352120A8 (en) Coating method
AU2002353369A8 (en) Anti-pirate method for the distribution of digital content
SG96641A1 (en) Method of electro-coating an article
HUP0401146A3 (en) Method for producing alkyl nitrites and alkyl dinitrites
AU2002366272A8 (en) Edg-receptor agonist for the treatment of hypertension
HU0100572D0 (en) Method for elimination of graphiti from big surface
HU0100184V0 (en) Method for forming of smokingset
HU0100382D0 (en) Method for determining dispersion of dimension of granules of polidisperse materials
GB0203197D0 (en) Delta opioid agonists
PL356317A1 (en) Method of obtaining alkanosulphonylpyridines

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)